Along the Value Chain. Interview with Hong Chow, GM of Roche Pharmaceuticals China.

By Mark Andrews

The Bridge. Spring 2017

China is already the second largest pharmaceutical market in the world and with increasing concerns about health, the market is sure to grow. Hong Chow, General Manager of Roche Pharmaceuticals China, talks with The Bridge about theChina market and how one of Switzerland’s most successful companies has positioned the country as an integral part of its world operations.

Can you outline Roche’s history of operations in China?

Roche first came to China in 1926, but at that time we only had a commercial presence. Then in 1994, we entered China by purchasing our current site in Shanghai’s Zhangjiang Hi-Tech Park and built a manufacturing plant. In 2004, we were the first multinational pharmaceutical company to establish a fully-owned research site in Shanghai. Then in 2007 we brought in clinical development – initially it was only for China and then it was upgraded for development work for the whole APAC region.

You can read the full article here

Mark Andrews has written about everything from Japanese houses to heli hikes on New Zealand glaciers, test drives of Chinese cars to bar and restaurant reviews. He currently specialises in travel articles and reviews of Chinese cars plus articles about the Chinese auto industry.

Let’s Get Started

Get in touch with Mark

All articles and photographs displayed on this web site are available for purchase with rights varying according to what has previously been sold. For most published articled this means first serial rights for the country that the publication appears in.

If you wish to speak to me about anything on this website or to discuss commissioning any work I can be contacted by:

Mobile phone

0086 13564588224

This is a Chinese mobile number. Please remember that China’s time zone is eight hours ahead of GMT.

Email Click to email Mark

3 + 13 =